XClinical’s “MARVIN4KIDS” at the DIA Geneva
XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the initiative “MARVIN4KIDS” for the first time at the DIA Annual EuroMeeting in Geneva. The conference takes place from March 28 to 30.
MARVIN4KIDS is an XClinical initiative to support child cancer care in cooperation with SIOP (International Society of Paediatric Oncology). XClinical has already been active in the area of child cancer research for several years already. The company has supported the GPOH (Society of Paediatric Oncology and Haematology) by providing a MARVIN licence at reduced costs. In SIOP XClinical has found an excellent partner sharing the belief, that in order to make better treatment possible it is necessary to invest energy, time and money in child cancer research and child cancer care. XClinical committed itself to donating 10,000€ to SIOP by the end of 2012. From March 2011 onwards XClinical will present the “MARVIN4KIDS” initiative at large clinical data management conferences. “We intend to make MARVIN4KIDS a real success for SIOP and XClinical. By supporting SIOP financially and by making more patients, families, doctors and researchers aware of SIOP’s great work, we hope to contribute to a future with excellent child cancer treatment. Thus we will frequently communicate this initiative to the clinical research community,” says Dr. Philippe Verplancke, CEO of XClinical.
SIOP has a vision that no child should die of cancer. To achieve this vision SIOP is committed to ensuring that each child and young adult with cancer has access to state-of-the-art treatment and care. Each year, more than 160,000 children worldwide are diagnosed with cancer while an estimated 90,000 die from the disease.
SIOP President Gabriele Calaminus notes: “Targeted scientific research and universal access to care and support for children and young adults with cancer must be made public health priorities in all countries, and now. SIOP is grateful for XClinical’s commitment to both support SIOP financially and to help raise awareness that through SIOP, doctors and researchers can make a real difference to the life of tomorrow’s child” says SIOP President Gabriele Calaminus.
Visit XClinical at booth No. 1220 to learn more about “MARVIN4KIDS” and SIOP.
Highlights at booth No. 1220
But there are more reasons for visiting booth No. 1220 besides the “MARVIN4KIDS” initiative. XClinical’s experts will be available during the exhibition for detailed discussions on CDISC-based tools for the end-to-end eClinical process such as the company’s EDC system MARVIN and the eCRF design tool STUDY COMPOSER. A special topic will be the IWR/IVR system ID-netTM developed by the Belgian CRO IDDI, now providing an interface to MARVIN.
For the first time ever XClinical will also host a Tuesday Networking Reception. On Monday and Tuesday vouchers for refreshments are available at the XClinical booth.
Established in 1969, the International Society of Paediatric Oncology (SIOP), with over 1500 members and a presence in over 100 countries, is the leading global professional society dedicated to children and young people who have cancer.
SIOP’s vision is that no child should die of cancer. To achieve this vision SIOP are committed to ensuring that each child and young adult with cancer has access to state of the art treatment and care. Through its annual congress SIOP plays its part in ensuring that the field of childhood cancer does not stand still, at the annual SIOP congress the outcomes of the best child cancer research and care are discussed.
Dr. Gabriele Calaminus is the President of SIOP. SIOP is governed by a board of directors and has its headquarters in Geneva, Switzerland.
Ira Hajdamacha, SIOP Office, Phone: +41 (0) 22 906 91 69
XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM).
Katharina Lang, XClinical GmbH, Phone: +49 (0)89 / 45 22 77 – 52 20,
80803 Munich / Germany
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release XClinical’s “MARVIN4KIDS” at the DIA Geneva here
News-ID: 168291 • Views: …
More Releases from XClinical GmbH
XClinical integrates INCA, Medical Coding software, with its EDC system MARVIN
XClinical releases version 1.6. of its coding system INCA XClinical GmbH, Munich, Germany, May 8, 2014 – XClinical, a global provider of eClinical solutions, today announces the availability of INCA version 1.6, medical coding software featuring MedDRA and WHODrug dictionaries, including an automated web interface to EDC systems such as MARVIN. INCA (“Integrated Coding Architecture”) is a web-based application that enables users to classify health related data such as patient medications and
XClinical CRO Executive Forum
XClinical hosts its first CRO Executive Forum on May 10, 2011 in Aying, Germany. XClinical GmbH, Munich, Germany – April 14, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, hosts its first CRO Executive Forum especially designed for CEOs of CROs on May 10, 2011 in Aying, Germany. The concept In 2010, XClinical started to provide
XClinical and IDDI: The best of 2 worlds
The IWR/IVR system ID-netTM developed by IDDI now provides an interface to MARVIN, XClinical’s EDC system XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the web-based open interface of IDDI’s ID-netTM to XClinical’s EDC system MARVIN at the DIA Annual EuroMeeting in Geneva. About ID-netTM ID-netTM
XClinical’s review of 2010
XClinical looks back on an innovative and extremely successful year XClinical GmbH, Munich, Germany – February 15th, 2011 – XClinical, European vendor of innovative software products for eClinical trials, well known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, had a very successful and innovative business year. Extended workforce Constant growth in the past years and the successful market relaunch of the STUDY COMPOSER as a standalone software tool
More Releases for Clinical
Clinical Laboratory Market in Indonesia, Clinical Laboratory Industry in Indones …
"Increase in healthcare expenditure from the Indonesian government has driven the growth of clinical laboratory market in Indonesia." Increase in Healthcare Awareness: Largely driven by increase in healthcare spending by aging population (~$ 260 per person by 2050), rising income levels, rising awareness for preventive testing, advanced healthcare diagnostic tests offerings, and central government's healthcare measures. Developments in Testing and Preference for Evidence based testing: There is also a rising number
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical